Form 4: BIO-KEY CEO Boosts Stake with Open Market Purchases
Insider Transaction Report
BIO-KEY International CEO Michael W. DePasquale increased his direct ownership of common stock through open market purchases on September 15 and 16, 2025.
Summary
- Michael W. DePasquale, the Chief Executive Officer and Chairman of BIO-KEY International Inc. (BKYI), acquired additional shares of common stock.
- On September 15, 2025, Mr. DePasquale purchased 2,500 shares of common stock at a price of $0.75 per share.
- Following this transaction, his direct beneficial ownership of common stock increased to 110,557 shares.
- On September 16, 2025, he acquired an additional 1,617 shares of common stock at a price of $0.84 per share.
- After the second transaction, his direct beneficial ownership of common stock totaled 112,174 shares.
- The reported holdings do not include options to purchase 232 shares and 9,167 shares issuable upon the exercise of warrants.
Sentiment
Score: 7
Explanation: The sentiment is positive due to significant insider buying by the CEO and Chairman, indicating strong management confidence in the company's prospects. While the total value of the purchases is modest, the act of direct investment by a key executive is a strong signal.
Positives
- The CEO and Chairman, Michael W. DePasquale, increased his direct ownership in the company, signaling confidence in BIO-KEY International's future prospects.
- Direct open market purchases by a key executive can be interpreted as a positive indicator of management's belief in the company's valuation and potential.
Future Outlook
This filing does not contain specific forward-looking statements or guidance regarding the company's future financial performance or strategic direction.
Industry Context
This insider transaction reflects an individual executive's investment decision and does not directly provide broader industry trends or competitive analysis. However, insider buying can sometimes be a leading indicator within an industry, suggesting an executive's belief in their company's position relative to peers.
Related Party Transactions
- Michael W. DePasquale, the Chief Executive Officer and Chairman, directly purchased common stock of BIO-KEY International Inc. on two separate occasions.
Stakeholder Impact
- Shareholders may view the CEO's increased stake as a positive sign of alignment between management and shareholder interests, potentially boosting investor confidence.
- Employees might perceive this as a vote of confidence in the company's stability and future, potentially impacting morale positively.
Key Dates
| Date | Description |
|---|---|
| 09/15/2025 | Transaction date for the acquisition of 2,500 shares of common stock by Michael W. DePasquale. |
| 09/16/2025 | Transaction date for the acquisition of 1,617 shares of common stock by Michael W. DePasquale. |
| 09/17/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed by Michael W. DePasquale. |
Recommendation
buyThe direct open market purchases by Michael W. DePasquale, the CEO and Chairman, signal strong insider confidence in BIO-KEY International Inc.'s future. While the individual transaction amounts are not exceptionally large, the act of a key executive increasing their personal stake is a positive indicator that often precedes favorable company performance. This suggests that management believes the stock is undervalued or has significant upside potential, making it a 'buy' signal for investors.
Keywords
BIO-KEY International, BKYI, Insider Trading, Stock Purchase, CEO, Common Stock, Executive Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.